We are live on
!
Find out more
SP
Sarasin & Partners Portfolio holdings
AUM
$8.54B
1-Year Est. Return
9.6%
This Fund
S&P 500
This Quarter
Est. Return
-3.62%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$9.95B
AUM Growth
-$1.03B
(-9.4%)
Cap. Flow
-$476M
Cap. Flow
% of AUM
-4.79%
Top 10 Holdings %
Top 10 Hldgs %
37.86%
Holding
102
New
6
Increased
27
Reduced
43
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ServiceNow
NOW
|
+$111M |
| 2 |
MPT
Medical Properties Trust
MPT
|
+$81.4M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$77.7M |
| 4 |
Walt Disney
DIS
|
+$70.2M |
| 5 |
Merck
MRK
|
+$65.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$261M |
| 2 |
CME Group
CME
|
+$118M |
| 3 |
Jack Henry & Associates
JKHY
|
+$105M |
| 4 |
Moody's
MCO
|
+$59.2M |
| 5 |
Costco
COST
|
+$58.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.92% |
| 2 | Financials | 15.37% |
| 3 | Industrials | 13.39% |
| 4 | Healthcare | 11.77% |
| 5 | Consumer Discretionary | 10.25% |
Similar funds
PCM
IC
NB
GRQ
ACM
DM
FT
PCIA
Sarasin & Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Sarasin & Partners held 102 positions worth $9.95B, down 9.4% from $11B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Sarasin & Partners withdrew a net $476M in Q1 2022, closing 14 positions and reducing 43 holdings. Its most notable exit was Edwards Lifesciences, an estimated $33M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
Against the trend, Sarasin & Partners opened a new position in Thermo Fisher Scientific worth $79.9M.
- Sarasin & Partners's largest Q1 2022 buy was Thermo Fisher Scientific: 135,237 shares worth $79.9M.
- Sarasin & Partners added most to ServiceNow in Q1 2022, an estimated $111M increase.
- Sarasin & Partners's biggest Q1 2022 reduction was Home Depot, cutting an estimated $261M.
- Sarasin & Partners fully exited Edwards Lifesciences in Q1 2022, selling an estimated $33M.
- Sarasin & Partners's ten largest holdings make up 38% of its $9.95B portfolio in Q1 2022.
- Sarasin & Partners opened 6 new positions and closed 14 in Q1 2022.
- Sarasin & Partners's portfolio value fell 9.4% quarter-over-quarter to $9.95B.
Based on Sarasin & Partners's 13F filing for Q1 2022, filed 11 Apr 2022.